8-K//Current report
Oyster Point Pharma, Inc. 8-K
Accession 0001193125-23-000324
CIK 0001720725operating
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 9:12 AM ET
Size
321.9 KB
Accession
0001193125-23-000324
Documents
- 8-Kd438605d8k.htmPrimary
8-K
- EX-3.1d438605dex31.htm
EX-3.1
- EX-3.2d438605dex32.htm
EX-3.2
- EX-101.SCHoyst-20230103.xsd
XBRL TAXONOMY EXTENSION SCHEMA
- EX-101.DEFoyst-20230103_def.xml
XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
- EX-101.LABoyst-20230103_lab.xml
XBRL TAXONOMY EXTENSION LABEL LINKBASE
- EX-101.PREoyst-20230103_pre.xml
XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
- XMLR1.htm
IDEA: XBRL DOCUMENT
- XMLd438605d8k_htm.xml
IDEA: XBRL DOCUMENT
- EXCELFinancial_Report.xlsx
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001193125-23-000324-xbrl.zip
IDEA: XBRL DOCUMENT
Issuer
Oyster Point Pharma, Inc.
CIK 0001720725
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001720725
Filing Metadata
- Form type
- 8-K
- Filed
- Jan 2, 7:00 PM ET
- Accepted
- Jan 3, 9:12 AM ET
- Size
- 321.9 KB